A report on the MACRO fasting trial describes more fat loss but similar total weight loss, with metabolic-rate and long-term questions.
On October 15, 2026, the British Journal of Nutrition published findings from the MACRO randomized clinical trial, according to Men’s Journal. The report described a 12-week study of 100 adults ages 20 to 60 with severe obesity.
The time-restricted-eating group had a modestly larger reported reduction in fat mass. Total weight loss was similar between groups and the report noted a greater decline in resting metabolic rate with time-restricted eating. The useful question is how to interpret those different outcomes without treating any one of them as the whole story.
According to Men’s Journal, both MACRO groups were prescribed calorie-restricted diets at approximately 60% of estimated daily energy expenditure. One group ate between 10 a.m. and 6 p.m. The comparison group followed calorie restriction without a restricted eating window.
That means the study tested an eight-hour eating window added to calorie restriction. It did not compare fasting with unrestricted eating. The shared dietary restriction is central to understanding what the trial was designed to assess.
A shorter window is a rule about when eating takes place. Calorie restriction is a rule about how much energy the diet provides. In MACRO, these approaches were combined in one group rather than tested as wholly separate alternatives.
The biological outcome also needs translation. Resting metabolic rate means the energy the body uses while at rest. Men’s Journal described the larger decline in the eating-window group as suggesting greater metabolic adaptation: a change in the body’s resting energy use during the intervention.
This makes the study about more than a number on the scale. It considers fat mass alongside total body weight and resting energy needs. Those measurements answer related questions, but they are not interchangeable.
For anyone putting fasting and hunger claims in context, the comparison is worth keeping clear. This was a test of whether adding a timing rule improved outcomes within a calorie-restricted approach. The prescribed diet and schedule describe the research protocol rather than a personal recommendation.
Men’s Journal emphasized a “Surprising Fat-Loss Advantage” in its headline. That emphasis reflects the reported difference in fat mass. But a fat-loss headline can sound like a claim of better overall weight-loss effectiveness, which is not what the report established.
The researchers’ conclusion was more restrained. As quoted in the report, combining fasting with calorie restriction “does not enhance weight loss.” The conclusion and the fat-mass finding are not necessarily contradictory because they concern different outcomes.
The broader reporting offers useful context. MarketWatch reported that a 2025 review of 99 randomized trials found modest weight loss with intermittent fasting compared with an unrestricted diet. Its summary also described little to no meaningful weight-loss difference compared with standard dietary advice such as calorie reduction.
This distinction changes the story being told. A comparison with unrestricted eating asks whether a structured approach helps relative to fewer dietary constraints. MACRO asks whether an extra timing rule adds something to an approach that already restricts calories. Evidence for the first question should not be treated as an answer to the second.
Johns Hopkins Medicine reported a separate 2026 trial in adults with obesity and prediabetes or diet-controlled type 2 diabetes. It compared a 10-hour eating window with a 16-hour usual-eating schedule over 12 weeks. Median weight loss was 2.7% and 2.5%, respectively.
That Johns Hopkins study is not MACRO and should not be merged with it. The broader lesson from these reports is to check the comparison before interpreting a fasting claim. An advantage over unrestricted eating is a different finding from an advantage over calorie restriction.
Men’s Journal reported that the eating-window group lost about 7.7 pounds of fat. The calorie-restriction-only group lost about 5.3 pounds. The reported difference was roughly 2.4 pounds over the study period.
Body composition was measured using DXA scans, according to the report. This gives the fat-loss finding a distinct place in the analysis rather than treating total weight change as the only outcome. It deserves attention without being promoted into a claim about every aspect of weight management.
The report put total weight loss at about 9.5 pounds in the eating-window group and 8.4 pounds in the calorie-restriction-only group. It said the difference was not statistically significant.
That does not prove the approaches are identical. It means the reported trial did not establish a total-weight advantage from adding the eating window. Describing the fasting group as clearly better for overall weight loss would therefore go beyond the result.
The size of the numerical difference and the statistical conclusion answer different questions. Here the report supplies both the weight-loss numbers and the statement that the between-group difference was not significant. The numerical ordering alone is not enough to change that conclusion.
These are group-level findings rather than predictions for an individual. The distinction between scale weight and body composition is also relevant when reading research focused on muscle preservation. A result should be named accurately before it becomes the basis for a practical decision.
The larger reported resting-metabolic-rate decline needs fuller detail. Men’s Journal did not give the size of that decline or enough statistical information to quantify the difference. The report therefore does not establish its clinical importance or whether the change persisted.
It would be misleading to turn that observation into a claim that fasting permanently slows metabolism. It would also be misleading to calculate a precise metabolic cost from information the article does not provide. The supported interpretation is a reported metabolic difference that needs further investigation.
The other limits belong alongside it. MACRO lasted 12 weeks and studied adults with severe obesity. That scope does not establish long-term weight maintenance or equivalent results for other populations and eating schedules.
The report also lacked detailed participant characteristics beyond age and severe obesity. It did not provide adherence, dropout or adverse-event data. Those gaps prevent a full assessment of how manageable the approach was or how its benefits and burdens were distributed among participants.
For example, an adherence measure would help explain whether participants consistently followed the assigned eating window. Dropout data would help show who remained in the study through the final assessment. Adverse-event reporting would be needed to assess tolerability. These are questions about the completeness of the evidence rather than reasons to assume the intervention was harmful.
Men’s Journal’s practical framing was that fasting may help some people organize eating. A shorter window is not automatically a better weight-loss strategy. Sustainability and the ability to maintain balanced eating remain relevant considerations rather than outcomes demonstrated by choosing a schedule.
A useful way to apply this evidence is to separate the research result from the appeal of a simple rule. An eating window can be easy to describe without being the best fit for every person. The trial is a reason to examine the structure thoughtfully rather than assume that more restriction means more benefit.
The choice need not become a judgment about discipline. A timing rule is an organizational tool to evaluate alongside nutrition and everyday habits. Preferring a different structure is not a failure to take health seriously. What matters for interpretation is the evidence behind the approach rather than how demanding the rule sounds.
For everyday decision-making, the study supports a few clear distinctions:
Personal choices about fasting or calorie restriction can be discussed with a qualified healthcare professional in the context of individual health needs and existing care. The reported calorie prescription should not be copied from a news story as a self-directed treatment plan. The most defensible takeaway is that meal timing is an option to assess rather than a requirement for successful weight management.
What to watch next: The next useful studies should track weight maintenance after the initial intervention and report resting-metabolic-rate changes in full. They should also document adherence and adverse events alongside body-composition outcomes. Before a restricted eating window becomes a standard preference over calorie restriction alone, the evidence needs to show a lasting advantage that matters in everyday life.
WeightRestart shares research-led guidance on weight loss, metabolism, nutrition, strength, appetite, sleep and recovery. Our goal is to make complex health information clear, practical and useful for people building progress they can maintain.
Learn how to build a weight-management approach around better information, realistic expectations and habits you can keep using.
read the blog
